HFE mutations in α-1-antitrypsin deficiency: An examination of cirrhotic explants

Modern Pathology

Volumn 23, Issue 5, 2010, Pages 637-643

  Lam, Maggie ^a   Torbenson, Michael ^b   Yeh, Matthew M ^c   Vivekanandan, Perumal ^a   Ferrell, Linda ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

A 1 antitrypsin deficiency; C282Y; Cirrhosis; H63D; Hemochromatosis; HFE mutation

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HFE GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

EID: 77952012348     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.42     Document Type: Article

References (18)

1. Fairbanks KD, Tavill AS. Liver disease in alpha 1-antitrypsin deficien cy: a review. Am J Gastroenterol 2008;103:2136-2141; quiz 42.
2. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 2004;350:2383-2397.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
4. McDonnell SM, Hover A, Gloe D, et al. Populationbased screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 1999;107:30-37.
5. Kowdley KV, Brandhagen DJ, Gish RG, et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005;129:494-503.
6. Shen R, Frankel WL, Wen P. Coexistent hereditary hemochromatosis and alpha1-antitrypsin deficiency. Arch Pathol Lab Med 2004;128:491-492.
7. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-888.
8. Rabinovitz M, Gavaler JS, Kelly RH, et al. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology 1992;16:145-148.
9. Fenton H, Torbenson M, Vivekanandan P, et al. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure. Transplantation 2009;87:1256-1260.
10. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001;154:193-206.
11. Fargion S, Bissoli F, Fracanzani AL, et al. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Hepatology 1996;24:1161-1164.
12. Sharrard MJ, Durkie M, Tanner MS. Genetic hemochromatosis in alpha1-antitrypsin-deficient liver disease. Hepatology 1997;26:1366.
13. Settin A, El-Bendary M, Abo-Al-Kassem R, et al. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis. J Gastrointestin Liver Dis 2006;15:131-135.
14. Geier A, Reugels M, Weiskirchen R, et al. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int 2004;24:285-294.
15. Pietrangelo A. Hemochromatosis gene modifies course of hepatitis C viral infection. Gastroenterology 2003;124:1509-1523.
16. Deugnier Y, Brissot P, Loreal O. Iron and the liver: update 2008. J Hepatol 2008; 48 (Suppl 1) : S113-S123.
17. Deugnier Y, Turlin B, le Quilleuc D, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997;21:669-675.
18. Lawless MW, Mankan AK, White M, et al. Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol 2007;8:30.